The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

November 2nd 2024

The 11 to 3 vote against the benefit-risk profile of sotagliflozin comes with less than 2 months to go until the December 20, 2024 PDUFA date.

10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity
10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity

October 30th 2024

Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center
Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD

October 21st 2024

US FDA LOGO IN BLACK OVER A WHITE BACKGROUND. | Credit: US Food and Drug Administration
FDA Issues Second CRL for Dasiglucagon (Zegalogue) in Congenital Hyperinsulinism

October 8th 2024

Pam Taub, MD | Credit: UC San Diego Health
Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial

October 8th 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.